Skip to main content

Table 3 Annual relapse rate (ARR) and relative reduction of relapse rate

From: Adherence and cost in multiple sclerosis patients treated with IM IFN beta-1a: impact of the CARE patient management program

Mean ARR

Participants (n = 190)

Non-participants (n = 137)

During12 months before baseline

1.2

1.2

From baseline to month 12 of study

0.5

0.5

Relative reduction of relapse rate

58 %

58 %